RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GUARINI A
Collezione AO Ordine Mauriziano

Items : 6

Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study. in British journal of haematology / Br J Haematol. 2023 Nov;203(4):637-650. doi: 10.1111/bjh.19104. Epub 2023 Sep 12.

2023
AO Ordine Mauriziano

Ocadlikova D; Lussana F; Fracchiolla N; Bonifacio M; Santoro L; Delia M; Chiaretti S; Pasciolla C; Cignetti A; Forghieri F; Grimaldi F; Corradi G; Zannoni L; De Propris S; Borleri GM; Tanasi I; Vadakekolathu J; Rutella S; Guarini AR; Foà R; Curti A;

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Della Porta MG; Santini V; Naldi I; Finelli C; Sancetta R; Selleri C; Pasini P; Giordano L; Turrini M; Tosi P; Tanasi I; Frigeni M; Grimaldi D; Marchetti M; Norata M; Galimberti S; Fianchi L; Di Veroli A; Ferrara F; Di Bona E; Bono R; Castelli A; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.

2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Piciocchi A; Cuneo A; Foà R; Rigolin GM; Fazi P; Neri A; Guarini A; Raponi S; Nanni M; De Propris MS; Della Starza I; Ibatici A; Murru R; Ruocco V; Del Giudice I; Varettoni M; Molinari A; Gentile M; Chiarenza A; Laurenti L; Gottardi D; Zinzani PL; Gozzetti A; Tani M; Musuraca G; Orsucci L; Re F; Di Renzo N; Liberati AM; et alii...

Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. in Oncoimmunology / Oncoimmunology. 2018 Feb 8;7(4):e1341032. doi: 10.1080/2162402X.2017.1341032. eCollection 2018.

2018
AO Ordine Mauriziano

Circosta P; Elia AR; Landra I; Machiorlatti R; Todaro M; Aliberti S; Brusa D; Deaglio S; Chiaretti S; Bruna R; Gottardi D; Massaia M; Giacomo FD; Guarini AR; Foà R; Kyriakides PW; Bareja R; Elemento O; Chichili GR; Monteleone E; Moore PA; Johnson S; Bonvini E; Cignetti A; Inghirami G;

Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study. in Annals of gastroenterology / Ann Gastroenterol. 2017;30(1):96-100. doi: 10.20524/aog.2016.0100. Epub 2016 Oct 27.

2017
ASL Asti
ASL Città di Torino
AO Ordine Mauriziano

Sinatora R; Zullo A; Schiavoni E; Sardi R; Puthiavettil R; Ongarelli C; Prinzio M; Onidi FM; Martino G; Marziali B; Mattiola R; Iudice S; Angelis A; Carretto D; Capaldi A; Biagini S; Guarini A;